Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2020
December 2020, Vol 11, No 6
December 2020, Vol 11, No 6
Changes to the Oncology Care Model Spurred by the COVID-19 Pandemic
By
Wayne Kuznar
Oncology Care Model
December 2020, Vol 11, No 6
The COVID-19 pandemic has spurred adjustments to the current Oncology Care Model (OCM) and is also affecting considerations for future models, according to Lara Strawbridge, MPH, Director, Division of Ambulatory Payment Models, Center for Medicare and Medicaid Innovation, who delivered the keynote address at the 2020 NCCN Oncology Policy Summit.
Read Article
Aggressive Approach to High-Risk Smoldering Myeloma Gains Consensus
By
Phoebe Starr
NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
Although smoldering myeloma is acknowledged as a clinical entity, debate continues about whether to treat, when to treat, and how to treat this condition, said Natalie S. Callander, MD, Leader, Myeloma/Lymphoma Disease-Oriented Team, University of Wisconsin Carbone Cancer Center, Madison, at the 2020 NCCN hematologic malignancies conference.
Read Article
Explosion of Treatment Regimens for Multiple Myeloma: Selecting the Right Option for the Right Patient
By
Phoebe Starr
Multiple Myeloma
,
NCCN 2020 Hematologic Malignancies
December 2020, Vol 11, No 6
At the 2020 NCCN hematologic malignancies conference, multiple myeloma expert Shaji Kumar, MD, Consultant and Professor of Medicine, Division of Hematology, Mayo Clinic Cancer Center, Rochester, MN, discussed the “bonanza of treatment regimens for multiple myeloma.”
Read Article
New Research Highlights Barriers to Clinical Trial Participation
By
Chase Doyle
Clinical Trials
December 2020, Vol 11, No 6
Enrollment in clinical trials is vital for the advancement of knowledge and improvement of patient outcomes, but few adults participate in cancer clinical trials. The numbers are even lower among minority adolescent and young adults (AYAs).
Read Article
Expert Insights on Innovation in the Oncology Pipeline
AVBCC 2020 Summit
December 2020, Vol 11, No 6
Total growth in the oncology pipeline in 2020 has been driven by targeted therapies, said Doug Long, Vice President, Industry Relations, IQVIA, at the 10th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2020.
Read Article
Recruiting Minorities to Clinical Trials
AVBCC 2020 Summit
December 2020, Vol 11, No 6
The COVID-19 pandemic has exposed many of the cracks in our healthcare system. According to Maurie Markman, MD, MS, FACP, FASCO, President, Medicine and Science, Cancer Treatment Centers of America, COVID-19 disproportionately affects the elderly, those with comorbidities, and racial and ethnic minority populations, all of whom are more likely to have serious or fatal illness. At the 10th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2020, Dr Markman served as a co-moderator of a session about minority representation in clinical trials.
Read Article
Economics and Inequities in Cancer Care: AVBCC Keynote Address
AVBCC 2020 Summit
December 2020, Vol 11, No 6
Greg Simon, JD, led the Cancer Moonshot program for the Obama administration, raising $1.8 billion in new funding for cancer research and the development of new cancer programs. In 2017, Joe Biden called on him to serve as President of the Biden Cancer Initiative. Mr Simon is also a survivor of chronic lymphocytic leukemia, a consultant and public speaker at Simonovation, LLC, and one of the thought leaders in cancer care.
Read Article
Payers’ Perspectives on Cancer Care
AVBCC 2020 Summit
December 2020, Vol 11, No 6
In an environment of increasing vertical and horizontal integration in healthcare, are new value-based care models in oncology—such as the Centers for Medicare & Medicaid Services’ pilot payment project, the Oncology Care Model (OCM)—working? Five years from now, will we still be talking about efforts to go from volume to value using alternative payment models?
Read Article
FGFR Inhibition in Cholangiocarcinoma and Resistance to Therapy
By
Chase Doyle
Cholangiocarcinoma
December 2020, Vol 11, No 6
In April 2020, the FDA granted accelerated approval to pemigatinib (Pemazyre), the first targeted therapy for cholangiocarcinoma (CCA). The
FGFR
inhibitor was approved for adults with CCA and
FGFR2
fusion.
Read Article
Cemiplimab Improves Survival versus Chemotherapy in Patients with Advanced NSCLC and PD-L1 ≥50%
By
Phoebe Starr
Lung Cancer
December 2020, Vol 11, No 6
First-line treatment with the high-affinity, highly potent PD-1 inhibitor cemiplimab-rwlc (Libtayo) significantly improved overall survival (OS) and progression-free survival (PFS) compared with standard platinum-based chemotherapy in patients with advanced non–small-cell lung cancer (NSCLC) and PD ligand 1 (PD-L1) expression on at least 50% of tumor cells. The results of the second preplanned interim analysis of the phase 3 EMPOWER-Lung 1 clinical trial were presented at the 2020 virtual meeting of the European Society for Medical Oncology (ESMO).
Read Article
Page 1 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Perioperative Nivolumab Extends Event-Free Survival in Resectable NSCLC
William King
2.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
3.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma